From July 1, 2022 to July 27, 2022, the company has repurchased 175,000 shares, representing 0.46% for ¥46.28 million. With this, the company has completed the repurchase of 350,000 shares, representing 0.93% for ¥692.31 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,799 JPY | +0.13% |
|
+1.77% | +13.23% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.23% | 910M | |
+54.16% | 803B | |
-7.21% | 351B | |
+17.96% | 324B | |
+10.71% | 303B | |
+16.70% | 243B | |
+2.25% | 228B | |
+10.78% | 217B | |
+6.62% | 164B | |
-4.08% | 155B |
- Stock Market
- Equities
- 4521 Stock
- News Kaken Pharmaceutical Co., Ltd.
- Tranche Update on Kaken Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.